Mangrove Partners’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Mangrove Partners’s Portfolio SHACW Stock Details SHACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-500,000	Closed	-$4.93M	–	432
2022 Q3	$4.93M	Buy	500,000 +147,797	+42%	+$7.36K	0.29%	123
2022 Q2	$3.46M	Buy	+352,203	New	+$49.1K	0.17%	241
2021 Q2	–	Sell	-20,400	Closed	-$12K	–	431
2021 Q1	$12K	Buy	+20,400	New	+$12.5K	﹤0.01%	309

Mangrove Partners's SHACW Position: Q4 2022 in Review

Mangrove Partners sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 500,000 shares — an estimated $4.93M sold.

Mangrove Partners first reported a position in SHACW in Q1 2021 and held it in 3 quarters. The position peaked at $4.93M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

Mangrove Partners reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
Mangrove Partners sold 500,000 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $4.93M.
Mangrove Partners first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 3 quarters.
Mangrove Partners's SCP & CO Healthcare Acquisition Company Warrant position peaked at $4.93M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Mangrove Partners's 13F filing for Q4 2022, filed 14 Feb 2023.